Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке:
https://open.uns.ac.rs/handle/123456789/30120
Назив: | Quercetin inhibits intestinal iron absorption and ferroportin transporter expression in vivo and in vitro | Аутори: | Lesjak Marija Hoque Rukshana Balesaria Sara Skinner Vernon Debnam Edward Srai Kaila Sharp Paul |
Датум издавања: | 2014 | Часопис: | PLoS ONE | Сажетак: | Balancing systemic iron levels within narrow limits is critical for maintaining human health. There are no known pathways to eliminate excess iron from the body and therefore iron homeostasis is maintained by modifying dietary absorption so that it matches daily obligatory losses. Several dietary factors can modify iron absorption. Polyphenols are plentiful in human diet and many compounds, including quercetin - the most abundant dietary polyphenol - are potent iron chelators. The aim of this study was to investigate the acute and longer-term effects of quercetin on intestinal iron metabolism. Acute exposure of rat duodenal mucosa to quercetin increased apical iron uptake but decreased subsequent basolateral iron efflux into the circulation. Quercetin binds iron between its 3-hydroxyl and 4-carbonyl groups and methylation of the 3-hydroxyl group negated both the increase in apical uptake and the inhibition of basolateral iron release, suggesting that the acute effects of quercetin on iron transport were due to iron chelation. In longer-term studies, rats were administered quercetin by a single gavage and iron transporter expression measured 18 h later. Duodenal FPN expression was decreased in quercetin-treated rats. This effect was recapitulated in Caco-2 cells exposed to quercetin for 18 h. Reporter assays in Caco-2 cells indicated that repression of FPN by quercetin was not a transcriptional event but might be mediated by miRNA interaction with the FPN 3′UTR. Our study highlights a novel mechanism for the regulation of iron bioavailability by dietary polyphenols. Potentially, diets rich in polyphenols might be beneficial for patients groups at risk of iron loading by limiting the rate of intestinal iron absorption. © 2014 Lesjak et al. 10.1371/journal.pone.0102900. | URI: | https://open.uns.ac.rs/handle/123456789/30120 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0102900 |
Налази се у колекцијама: | PMF Publikacije/Publications |
Приказати целокупан запис ставки
SCOPUSTM
Навођења
86
проверено 10.05.2024.
Преглед/и станица
18
Протекла недеља
8
8
Протекли месец
0
0
проверено 10.05.2024.
Google ScholarTM
Проверите
Алт метрика
Ставке на DSpace-у су заштићене ауторским правима, са свим правима задржаним, осим ако није другачије назначено.